LMT503

LMT503 · Lmito Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LMT503, covering 2024-10-23 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: LMT503 First-in-human SAD, MAD, and FE Study [Phase 1]